(Q45871489)

17 December 2017

title

Hepatocyte growth factor both prevents and ameliorates the symptoms of dermal sclerosis in a mouse model of scleroderma (English)

1 reference

17 December 2017

author name string

Wu MH

1

1 reference

17 December 2017

Yokozeki H

2

1 reference

17 December 2017

Takagawa S

3

1 reference

17 December 2017

Yamamoto T

4

1 reference

17 December 2017

Satoh T

5

1 reference

17 December 2017

Kaneda Y

6

1 reference

17 December 2017

Katayama I

7

1 reference

17 December 2017

Nishioka K

8

1 reference

17 December 2017

publication date

1 January 2004

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

11

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

170-180

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302165

exact match

0 references

cites work

Systemic scleroderma. Clinical and pathophysiologic aspects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302165

A brief overview of the pathogenesis of scleroderma (systemic sclerosis)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302165

Molecular cloning and expression of human hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302165

Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302165

Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus): reciprocal effect of cationic lipid for in vitro and in vivo gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302165

Hepatocyte growth factor gene therapy of liver cirrhosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302165

Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302165

Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302165

Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302165

Hepatocyte growth factor as a potent survival factor for rat pheochromocytoma PC12 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302165

Safety evaluation of hemagglutinating virus of Japan--artificial viral envelope liposomes in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302165

Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302165

Animal models of systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302165

7 January 2021

Dermal sclerosis in the lesional skin of 'flagellate' erythema (scratch dermatitis) induced by bleomycin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302165

7 January 2021

Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302165

7 January 2021

Effect of interferon-gamma on experimental scleroderma induced by bleomycin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302165

7 January 2021

Anti-sclerotic effect of transforming growth factor-beta antibody in a mouse model of bleomycin-induced scleroderma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302165

7 January 2021

Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302165

7 January 2021

Influence of luminal hepatocyte growth factor on small intestine mucosa in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302165

7 January 2021

Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302165

7 January 2021

Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302165

7 January 2021

Reciprocal balance of hepatocyte growth factor and transforming growth factor-beta 1 in renal fibrosis in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302165

7 January 2021

Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302165

7 January 2021

Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302165

7 January 2021

Dermal papilla cells express hepatocyte growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302165

7 January 2021

Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302165

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302165

1 reference

17 December 2017

Dimensions Publication ID

1000339287

0 references

1 reference

17 December 2017